120 related articles for article (PubMed ID: 17276375)
1. In search of effective anti-HHV-6 agents.
De Clercq E; Naesens L
J Clin Virol; 2006 Dec; 37 Suppl 1():S82-6. PubMed ID: 17276375
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
Naesens L; Bonnafous P; Agut H; De Clercq E
J Clin Virol; 2006 Dec; 37 Suppl 1():S69-75. PubMed ID: 17276373
[TBL] [Abstract][Full Text] [Related]
3. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.
De Bolle L; Andrei G; Snoeck R; Zhang Y; Van Lommel A; Otto M; Bousseau A; Roy C; De Clercq E; Naesens L
Biochem Pharmacol; 2004 Jan; 67(2):325-36. PubMed ID: 14698045
[TBL] [Abstract][Full Text] [Related]
4. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses.
Naesens L; Stephens CE; Andrei G; Loregian A; De Bolle L; Snoeck R; Sowell JW; De Clercq E
Antiviral Res; 2006 Oct; 72(1):60-7. PubMed ID: 16650489
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.
De Bolle L; Manichanh C; Agut H; De Clercq E; Naesens L
Antiviral Res; 2004 Oct; 64(1):17-25. PubMed ID: 15451175
[TBL] [Abstract][Full Text] [Related]
8. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
[TBL] [Abstract][Full Text] [Related]
9. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.
Naesens L; Lenaerts L; Andrei G; Snoeck R; Van Beers D; Holy A; Balzarini J; De Clercq E
Antimicrob Agents Chemother; 2005 Mar; 49(3):1010-6. PubMed ID: 15728896
[TBL] [Abstract][Full Text] [Related]
10. Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication.
Neyts J; Balzarini J; Andrei G; Chaoyong Z; Snoeck R; Zimmermann A; Mertens T; Karlsson A; De Clercq E
Mol Pharmacol; 1998 Jan; 53(1):157-65. PubMed ID: 9443944
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
Isegawa Y; Hara J; Amo K; Osugi Y; Takemoto M; Yamanishi K; Fukunaga R; Shibata M; Ohshima A; Horiguchi Y; Sugimoto N
J Clin Virol; 2009 Jan; 44(1):15-9. PubMed ID: 18952495
[TBL] [Abstract][Full Text] [Related]
12. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase.
Safronetz D; Petric M; Tellier R; Parvez B; Tipples GA
J Med Virol; 2003 Nov; 71(3):434-9. PubMed ID: 12966551
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antiviral compounds against human herpesvirus 6 and 7.
Yoshida M; Yamada M; Tsukazaki T; Chatterjee S; Lakeman FD; Nii S; Whitley RJ
Antiviral Res; 1998 Dec; 40(1-2):73-84. PubMed ID: 9864048
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
15. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
[TBL] [Abstract][Full Text] [Related]
16. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.
Akhyani N; Fotheringham J; Yao K; Rashti F; Jacobson S
J Neurovirol; 2006 Aug; 12(4):284-93. PubMed ID: 16966219
[TBL] [Abstract][Full Text] [Related]
19. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of human CMV.
Andrei G; De Clercq E; Snoeck R
Curr Opin Investig Drugs; 2008 Feb; 9(2):132-45. PubMed ID: 18246516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
